Urticaria-like rash in a patient with COVID-19 associated pneumonia of moderate severity: aspects of pathogenesis
- Authors: Orlova E.V.1, Smirnova L.M.2, Melikova N.I.2, Popova K.Y.2
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University (Sechenov University)
- First Moscow State Medical University (Sechenov University)
- Issue: Vol 23, No 2 (2020)
- Pages: 109-114
- Section: CLINICAL PICTURE, DIAGNOSIS, AND THERAPY OF DERMATOSES
- URL: https://journals.rcsi.science/1560-9588/article/view/41933
- DOI: https://doi.org/10.17816/dv41933
- ID: 41933
Cite item
Abstract
In mid 2020, the number of new coronavirus (COVID-19) cases has exceeded globally six million. The clinical manifestations of COVID-19 infection are numerous mostly causing damage to the bronchopulmonary system in the form of a dry cough, rhinitis, dyspnea, fever, myalgia, and general weakness. Skin manifestations of COVID-19 are rare and currently include five types of skin lesions occurring during the infection process, which are reliably recorded in only a limited number of case reports and certain analytical publications. This article describes the clinical case of a 28-year-old patient with urticaria-like disseminated rash and confirmed COVID-19-associated pneumonia.
Full Text
##article.viewOnOriginalSite##About the authors
Ekaterina V. Orlova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Author for correspondence.
Email: orlovaderm@yandex.ru
Department of Dermatology and Venereology
Russian Federation, 119991, MoscowL. M. Smirnova
First Moscow State Medical University (Sechenov University)
Email: orlovaderm@yandex.ru
Department of Dermatology and Venereology of I.M. Sechenov
Russian Federation, Moscow, 119991N. I. Melikova
First Moscow State Medical University (Sechenov University)
Email: orlovaderm@yandex.ru
Department of Dermatology and Venereology of I.M. Sechenov
Russian Federation, Moscow, 119991K. Yu. Popova
First Moscow State Medical University (Sechenov University)
Email: orlovaderm@yandex.ru
Department of Dermatology and Venereology of I.M. Sechenov
Russian Federation, Moscow, 119991References
- Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y., et al. Early transmission dynamics in Wuhan, China, of novel coronavirus –
- infected pneumonia. N Engl J Med. 2020; 382(13): 1199-207.
- Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., et al.; China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019.
- N. Engl. J. Med. 2020; 382(8): 727-33.
- World Health Organization Press Conference. The World Health Organization (WHO) Has Officially Named the Disease Caused by the Novel Coronavirus as COVID-19. [Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed on 11 Febr 2020].
- Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. BioRxiv. 2020. [Available at: https://www.biorxiv.org/content/10.1101/2020.02.07.937862v1. Accessed on 11 Febr 2020]. DOI: https://doi.org/10.1101/2020.02.07.937862
- The World Health Organization (WHO) Coronavirus Disease (COVID-2019) Dashboard. [Available on: https://covid19.who.int. Access on 30 May 2020].
- Temporary Methodical Recommendations “Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)” of the Ministry of Health of the Russian Federation (Ver. 6, 24.04.2020). Available on: https://www.rosminzdrav.ru/ministry/med_covid19. Access on 30 April 2020]. (in Rissian)
- Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., et al.; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18): 1708-20.
- Hedou M., Carsuzaa F., Chary E., Hainaut E., Cazenave-Roblot F., Masson Regnault M. Comment on “Cutaneous manifestations in COVID-19: a first perspective” by Recalcati S. J Eur Acad Dermatol Venereol. 2020. doi: 10.1111/jdv.16519. Online ahead of print.
- Mahe A., Birckel E., Krieger S., Merklen C., Bottlaender L. A distinctive skin rash associated with Coronavirus Disease 2019? J Eur Acad Dermatol Venereol. 2020. DOI: https://doi.org/10.1111/jdv.16471. Online ahead of print.
- Mollaret G. Covid-19: les dermatologues appellant à la vigilance sur les acrosyndromes et érythèmes faciaux. Le quotidien du medecin. 2020. [Available on: https://www.lequotidiendumedecin.fr/specialites/dermatologie/covid-19-les-dermatologues-appellent-la-vigilance-sur-les-acrosyndromes-et-erythemes-faciaux. Access on 30 April 2020].
- Redford T., Al-Dissi A.N. Feline infectious peritonitis in a cat presented because of papular skin lesions. Can Vet J. 2019; 60(2): 183-185.
- Casas C.G., Catala A., Hernandez Carretero G., Rodriguez-Jimenez P., Fernandez Nieto D., Rodríguez-Villa Lario A., et al. Classification of the cutaneous manifestations of COVID-19: A Rapid Prospective Nationwide Consensus Study in Spain with 375 cases. Br J Dermatol. 2020. doi: 10.1111/bjd.19163. Online ahead of print.
- Gianotti R., Zerbi P., Dodiuk-Gad R.P. Clinical and histopathological study of skin dermatoses in patients affected by COVID-19 infection in the Northern Part of Italy. J Dermatol Sci. 2020; S0923-1811(20)30143-2. doi: 10.1016/j.jdermsci.2020.04.007. Online ahead of print.
- Sachdeva M., Gianotti R., Shah M., Lucia B., Tosi D., Veraldi S., et al. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. J Dermatol Sci. 2020.
- doi: 10.1016/j.jdermsci.2020.04.011. Online ahead of print.
- Manalo I.F., Smith M.K., Cheeley J., Jacobs R. A dermatologic manifestation of COVID-19: transient livedo reticularis,
- J. Am. Acad. Dermatol. 2020. DOI: https://dx.doi.org/10.1016/j.jaad.2020.04.018. [Available on: https://www.researchgate.net/publication/340559100_A_Dermatologic_Manifestation_of_COVID-19_Transient_Livedo_Reticularis]
- Magro C., Mulvey J., Berlin D., Nuovo G., Salvatore S., Harp J., et al. Complementary associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020; S1931-5244(20)30070-0. doi: 10.1016/j.trsl.2020.04.007. Online ahead of print.